Clinical Study of the Sonablate® 500 to Treat Localized (T1c/T2a) Prostate Cancer (SetPace)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00770822
Recruitment Status : Unknown
Verified December 2013 by SonaCare Medical.
Recruitment status was:  Active, not recruiting
First Posted : October 10, 2008
Last Update Posted : January 12, 2016
Information provided by (Responsible Party):
SonaCare Medical

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Primary Completion Date : July 2013
  Estimated Study Completion Date : December 2017